XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 152,161 Value ($000) $1,239 Avg Close $6.64 Range $4.52 - $8.35
Q2 2025
Shares 138,092 Value ($000) $645 Avg Close $4.58 Range $3.81 - $5.50
Q1 2025
Shares 142,104 Value ($000) $780 Avg Close $4.04 Range $3.14 - $6.07
Q4 2024
Shares 129,952 Value ($000) $198 Avg Close $3.22 Range $2.69 - $3.87
Q3 2024
Shares 23,799 Value ($000) $68 Avg Close $2.57 Range $2.03 - $3.04
Q1 2024
Shares 35,375 Value ($000) $78 Avg Close $2.59 Range $2.00 - $3.26
Q4 2023
Shares 25,978 Value ($000) $61 Avg Close $1.85 Range $1.46 - $2.44
Q3 2023
Shares 25,978 Value ($000) $43 Avg Close $2.29 Range $1.73 - $2.78
Q2 2023
Shares 25,978 Value ($000) $66 Avg Close $2.55 Range $1.64 - $3.07